[14C-labeling of D 16,427, a new positive inotropic agent]

Does [meso-1,2-bis(2,6-dichloro-4-hydroxyphenyl)ethylenediamine] dichloroplatinum(II) act as an immune response modifier? IV. Inhibition of the proliferation-increasing effect of progressively growing MXT-M-3,2 breast cancer on phagocytes by the title compound.

Archiv der Pharmazie·2002

1-(2,6-dichloro-4-hydroxyphenyl)-2-phenylethanes--new biological response modifiers for the therapy of breast cancer. Synthesis and evaluation of estrogenic/antiestrogenic properties.

Archiv der Pharmazie·2001

Does [meso-1,2-bis(2,6-dichloro-4-hydroxyphenyl)ethylenediamine]- dichloro-platinum(II) act as an immune response modifier? Part III: Progressively growing MXT-M-3,2 breast cancer stimulates the proliferation of phagocytes in B6D2F1 mice.

Archiv der Pharmazie·2001

Does [meso-1,2-bis(2,6-dichloro-4-hydroxyphenyl)ethylenediamine]- dichloroplatinum(II) act on the hormone-sensitive, murine breast cancer as a biological response modifier? Part II. Studies on the influence of [meso-1,2-bis(2,6-dichloro-4-hydroxyphenyl)ethylenediamine] dichloroplatinum(II) on the specific immune defense in MXT-M-3,2 breast cancer bearing mice.

Archiv der Pharmazie·2001

[Aqua-1-(2,6-dichloro-4-hydroxyphenyl)-2-phenylethylenediamine] sulfatoplatinum(II) complexes with variable substituents in the 2-phenyl ring. 3. Investigation of breast cancer inhibiting properties.

Journal of cancer research and clinical oncology·2000

Does [meso-1,2-bis(2,6-dichloro-4-hydroxyphenyl)ethylenediamine]- dichloroplatinum(II) act on the hormone-sensitive, murine breast cancer as a biological response modifier? Part 1: The MXT-M-3.2 breast cancer stimulates the growth of an identical second graft; [meso-1,2-bis(2,6-dichloro-4-hydroxyphenyl)ethylenediamine]dichloroplat inum (II) inhibits this process.

Archiv der Pharmazie·2000

Recent Developments and Structure-Activity Relationships of BRAF Inhibitors for Cancer Drug Discovery.

Archiv der Pharmazie·2026

Structural Modifications of Nonsteroidal Anti-Inflammatory Drugs (NSAIDs): New Horizons in Antimicrobial Drug Discovery.

Archiv der Pharmazie·2026

Benzophenone Derivatives as a New Class of Anti-Infectives Against Acanthamoeba spp.

Archiv der Pharmazie·2026

Synthesis and Characterization of Tritium-Labeled Neuropeptide Y Y5 Receptor Ligands Derived From CGP71683A.

Archiv der Pharmazie·2026

Olikomycin A Disrupts Gram-Positive Bacterial Membranes Through Calcium-Dependent Binding to Phosphatidylglycerol.

Archiv der Pharmazie·2026

Venom-Derived Peptides in Breast Cancer: Pharmacological Mechanisms and Medicinal Chemistry-Guided Translational Development.

Archiv der Pharmazie·2026

Dealing with membrane stress through CASM.

Autophagy·2026

A Novel Equipment for VLE Studies: Ethanol and Water System at Moderate Pressures and Data Verification with a Direct Point-to-Point Test.

ACS omega·2026

Mechanism of injury and fracture status influence outcomes after central cord injury.

iScience·2026

TEX15 safeguards neuronal diversity in the mouse olfactory system.

bioRxiv : the preprint server for biology·2026

Flexible Sensor Array Based on Polythiophene/Cu-MOF-Derived CuO and Polyaniline/MXene Composites for Room-Temperature Detection of Hydrogen Sulfide and Ammonia.

ACS sensors·2026

Anoctamin 2 deletion alters dopamine-related signaling and impairs inhibitory behavioral control in mice.

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology·2026

Related Experiment Videos

[14C-labeling of D 16,427, a new positive inotropic agent]

Related Concept Videos

Does [meso-1,2-bis(2,6-dichloro-4-hydroxyphenyl)ethylenediamine] dichloroplatinum(II) act as an immune response modifier? IV. Inhibition of the proliferation-increasing effect of progressively growing MXT-M-3,2 breast cancer on phagocytes by the title compound.

1-(2,6-dichloro-4-hydroxyphenyl)-2-phenylethanes--new biological response modifiers for the therapy of breast cancer. Synthesis and evaluation of estrogenic/antiestrogenic properties.

Does [meso-1,2-bis(2,6-dichloro-4-hydroxyphenyl)ethylenediamine]- dichloro-platinum(II) act as an immune response modifier? Part III: Progressively growing MXT-M-3,2 breast cancer stimulates the proliferation of phagocytes in B6D2F1 mice.

[Aqua-1-(2,6-dichloro-4-hydroxyphenyl)-2-phenylethylenediamine] sulfatoplatinum(II) complexes with variable substituents in the 2-phenyl ring. 3. Investigation of breast cancer inhibiting properties.

Recent Developments and Structure-Activity Relationships of BRAF Inhibitors for Cancer Drug Discovery.

Structural Modifications of Nonsteroidal Anti-Inflammatory Drugs (NSAIDs): New Horizons in Antimicrobial Drug Discovery.

Benzophenone Derivatives as a New Class of Anti-Infectives Against Acanthamoeba spp.

Synthesis and Characterization of Tritium-Labeled Neuropeptide Y Y5 Receptor Ligands Derived From CGP71683A.

Olikomycin A Disrupts Gram-Positive Bacterial Membranes Through Calcium-Dependent Binding to Phosphatidylglycerol.

Venom-Derived Peptides in Breast Cancer: Pharmacological Mechanisms and Medicinal Chemistry-Guided Translational Development.

Dealing with membrane stress through CASM.

A Novel Equipment for VLE Studies: Ethanol and Water System at Moderate Pressures and Data Verification with a Direct Point-to-Point Test.

Mechanism of injury and fracture status influence outcomes after central cord injury.

TEX15 safeguards neuronal diversity in the mouse olfactory system.

Flexible Sensor Array Based on Polythiophene/Cu-MOF-Derived CuO and Polyaniline/MXene Composites for Room-Temperature Detection of Hydrogen Sulfide and Ammonia.

Anoctamin 2 deletion alters dopamine-related signaling and impairs inhibitory behavioral control in mice.

Related Experiment Videos

[14C-labeling of D 16,427, a new positive inotropic agent]

Related Concept Videos

Related Articles